Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.
about
Purinergic signalling and cancerThe A(2A)-adenosine receptor: a GPCR with unique features?The mTOR pathway and integrating immune regulationFrequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapyAutoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppressionAn intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling.Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment.Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cellsAutoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injuryComprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy.Immune profiling and cancer post transplantationRadiation enhances regulatory T cell representation.Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologistsCaffeine Improves Heart Rate Without Improving Sepsis SurvivalAlterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCIDAnti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors.Adenosine A2A receptor plays an important role in radiation-induced dermal injuryTargeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer.Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease.Modifying radiation damage.NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model.Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation.cAMP during HIV infection: friend or foe?The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).Design and application of locally delivered agonists of the adenosine A(2A) receptor.The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.CD73 and adenosine generation in the creation of regulatory microenvironments.Purinergic signalling and immune cells.Regulatory T cells and potential inmmunotherapeutic targets in lung cancer.Potential Therapeutic Applications of Adenosine A2A Receptor Ligands and Opportunities for A2A Receptor Imaging.Role of Metabolism in the Immunobiology of Regulatory T Cells.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg).Tissue metabolism and the inflammatory bowel diseases.Adenosine: tipping the balance towards hepatic steatosis and fibrosis.Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.
P2860
Q24618782-752AF4D2-0D8E-46F2-8163-D2080C5C9CDDQ24653743-8EBA438F-46E6-4AF4-AB91-DEECA569D5B8Q26830354-52D4CBD5-F964-4630-9AF5-29DF7C68F4BCQ28741958-3E58ABCB-0578-439C-B208-DAFBF864F36DQ33403252-25E884BD-CA27-4E11-846F-8776953FBACDQ33533705-C593A69C-F0DA-4011-B300-CB3239F3BEC2Q33987134-10DD4084-EEBC-4371-B238-6FC383315318Q34100538-45E34227-BB9E-40E8-951D-205FB7171F3BQ34107172-4B723061-40BE-474D-9E08-348682C6EC80Q34292449-BB0D7A5B-57A6-47E2-B756-CE5F819C0B25Q34487847-F80C52CE-ABA2-4B23-8FBF-4ACD4FB50162Q34667755-E92ADFBD-12AD-4832-855B-9C1717785072Q35050810-3F0C415B-8350-4A23-AFBC-96440C2BB6D6Q35053414-E77BEBC9-6A3B-44AC-BBCD-773A1695D12AQ35090797-00A8AF5C-2579-4A3B-9D6D-B921C78C8C80Q35858571-C62E19E0-1360-4F22-A3FF-927C7DD79792Q36185196-6F8BAB47-814A-4B0A-8B91-8D9733559D56Q36362887-8CFEBEE1-FB9B-4911-936F-664A77D209E6Q36385392-B88CF1C8-63C0-4A6C-8084-AC03C4282A18Q36620552-E3485FAC-0AF9-4F6A-B06F-AC9D5DFBB613Q36821572-965E65C6-FC01-4EC6-96A0-06CBCAE7F96EQ36907484-9A4EDA73-31A8-4AA2-BE2D-8F3A8C3A731EQ37768190-F182A0E7-82DE-4D2A-B5F6-E4A1C87EE253Q37868181-3A480B25-B431-4FDD-AE10-75643EE6D171Q37876541-DC1F97D5-007B-43A2-A663-05533042B59FQ37894107-5CD72845-A1BE-4CB1-941A-96EBA3F9A53CQ37931979-C6E799B3-BFE9-44A0-ABBD-AC06A8CF3E3AQ37956691-B6458485-3A4A-418D-A7E1-0715CCAAA4D5Q37960072-792A31D6-3090-484A-98CC-1A3ABCF26B1BQ38063159-BD1CAC68-A824-4F9D-A939-D27EC9536273Q38063958-B711AFAC-DCB8-4B62-8390-463931B867F0Q38263455-CDCB8DAB-5B38-498D-B092-00552B142039Q38473314-4A2CBDC9-115C-4F8B-9F05-206C50AC927DQ38765118-47E776AF-AD06-40F4-BBC6-BCB732C2574CQ38957379-C748ED30-B100-4767-96F8-283AF7CA457EQ39157059-91E2CBC9-900D-4C89-BAF6-1140FF1A97F3Q39281335-2EB8C294-BE95-41AA-B2E7-4235E5AEA8D4Q39320456-598B9736-F1F8-4CCC-8D40-1C8E1BE34138Q40712355-A70774F6-687F-40DE-A160-8CE94120FD68Q41832380-59EA521D-BF66-4D04-A824-7F2AE6DB3185
P2860
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@ast
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@en
type
label
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@ast
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@en
prefLabel
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@ast
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@en
P2093
P2860
P356
P1476
Adenosine A2A receptor antagon ...... ffects and T regulatory cells.
@en
P2093
P2860
P304
P356
10.1038/BJP.2008.23
P407
P478
153 Suppl 1
P577
2008-03-01T00:00:00Z